Loading chat...

MI HR0330

Resolution

Official Source

Status

Introduced

7/1/2022

Primary Sponsor

Julie Rogers

Click for details

Origin

House of Representatives

101st Legislature

AI Summary

  • Urges the FDA to facilitate FDA-approved research on hyperbaric oxygen therapy for treating Traumatic Brain Injury (TBI) and Post Traumatic Stress Disorder (PTSD) in veterans
  • Cites that an estimated 877,450 veterans nationwide and 24,201 Michigan veterans suffer from TBI and PTSD, conditions linked to increased suicide rates and opioid use
  • Notes hyperbaric oxygen therapy is already FDA-approved for treating various conditions including non-healing wounds, crush injuries, burns, and radiation injury
  • References that over 750 patients in neurological studies and over 10,000 veterans in private clinics have been successfully treated with hyperbaric oxygen therapy for brain wounds, showing improved quality of life and reduced suicidal ideation
  • Directs that copies of the resolution be transmitted to the Commissioner of the FDA

Legislative Description

A resolution to urge the United States Food and Drug Administration to facilitate FDA approved research on hyperbaric oxygen therapy for the treatment of Traumatic Brain Injury and Post Traumatic Stress Disorder.

Last Action

Referred To Committee On Health Policy

7/1/2022

Committee Referrals

Health Policy7/1/2022

Full Bill Text

No bill text available